Innoviva, Inc. (INVA)
21.63
-0.17
(-0.78%)
USD |
NASDAQ |
Feb 09, 16:00
21.89
+0.26
(+1.20%)
Pre-Market: 08:32
Innoviva Accounts Payable (Quarterly) : 6.243M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Nektar Therapeutics | 15.56M |
| Oramed Pharmaceuticals, Inc. | 0.56M |
| Theravance Biopharma, Inc. | 2.213M |
| Axsome Therapeutics, Inc. | 54.23M |
| Keros Therapeutics, Inc. | 2.298M |